eprodisate prodrug (BELLUS)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameeprodisate prodrug (BELLUS)
Drug Alias NameNC-503 prodrug (BELLUS)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycosaminoglycan modulators
TargetsGlycosaminoglycan
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBellus Health Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBellus Health Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A